JCR Pharmaceuticals Co., Ltd.
Records under this name other than the patents JCR Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 38 patents it holds.
Back to JCR Pharmaceuticals Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,974,791 | Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the CNS Formerly held In force · High confidence | In force | High confidence | |
| US 9,526,831 | Pharmaceutical Injection Device Formerly held In force · High confidence | In force | High confidence | |
| US 9,623,180 | Pharmaceutical Injection System Formerly held In force · High confidence | In force | High confidence | |
| US 9,744,310 | Pharmaceutical Injection Device Formerly held In force · High confidence | In force | High confidence | |
| US 10,174,284 | Medium, for Culturing Corneal Endothelial Cells, Containing Conditioned Medium from Mesenchymal Stem Cells Formerly held In force · High confidence | In force | High confidence | |
| US 10,335,439 | Method for Producing Human Corneal Epithelium Sheet Formerly held In force · High confidence | In force | High confidence | |
| US 10,518,033 | Pharmaceutical Cartridge Holding Unit, and Pharmaceutical Injection Device Provided Therewith Formerly held In force · High confidence | In force | High confidence | |
| US 10,759,749 | Novel Therapeutic Agent for Diabetes Formerly held In force · High confidence | In force | High confidence | |
| US 8,759,297 | Genetically Encoded Multifunctional Compositions Bidirectionally Transported Between Peripheral Blood and the CNS Lapsed on the fee record Ended Jun 24, 2026 · High confidence | Lapsed on the fee record | Ended Jun 24, 2026 | High confidence |
| US 8,753,610 | Methods for Diagnosing CNS Disorders with Fusion Antibodies That Cross the Blood-Brain Barrier in Both Directions Lapsed on the fee record Ended Jun 17, 2026 · High confidence | Lapsed on the fee record | Ended Jun 17, 2026 | High confidence |